Based on 2 analysts offering 12 month price targets for Cardiol Therapeutics Inc
Min Forecast
$8.00+471.43%
Avg Forecast
$8.50+507.14%
Max Forecast
$9.00+542.86%
Should I buy or sell CRDL stock?
Based on 2 analysts offering ratings for Cardiol Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CRDL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CRDL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their CRDL stock forecasts and price targets.
Is Cardiol Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: CRDL) stock is to Strong Buy CRDL stock.
Out of 2 analysts, 1 (50%) are recommending CRDL as a Strong Buy, 1 (50%) are recommending CRDL as a Buy, 0 (0%) are recommending CRDL as a Hold, 0 (0%) are recommending CRDL as a Sell, and 0 (0%) are recommending CRDL as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year CRDL price target, the average CRDL price target is $8.50, with the highest CRDL stock price forecast at $9.00 and the lowest CRDL stock price forecast at $8.00.
On average, Wall Street analysts predict that Cardiol Therapeutics's share price could reach $8.50 by Apr 6, 2027. The average Cardiol Therapeutics stock price prediction forecasts a potential upside of 507.14% from the current CRDL share price of $1.40.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.